BioSpace News Archive

DAVITA INC. announced that it has commenced a modified “Dutch auction” tender offer for up to $1.2 billion of its common stock at a price per share not less than $53.50 and not greater than $61.50.

CalTree™ software to be important piece of company-wide calibration automation platform expected to drive greater Service segment efficiencies and enhanced margins

Compugen Ltd. announced that the Company will release its second quarter 2019 financial results on Monday, August 5, 2019 before the U.S. financial markets open.

Disarm Therapeutics, a biotechnology company creating a new class of disease-modifying therapeutics for patients with axonal degeneration, a central driver of neurological disease, today announced the appointment of Alvin Shih, M.D., MBA, as President and Chief Executive Officer.

IQVIA Holdings Inc. (“IQVIA™”) (NYSE: IQV) has been named to the Forbes 2019 list of America’s Best Employers for Women

The Jim Rutt Show with guest Cory Doctorow

Northwell Health and Integrated Oncology Network, LLC (ION) today announced a joint collaboration to operate a radiation oncology center in Forest Hills, Northwell’s first radiation therapy center in Queens.

Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that Memorial Sloan Kettering Cancer Center (MSK) in New York, NY will investigate the potential use of Kazia’s investigational new drug, GDC-0084, in combination with radiotherapy in a phase I clinical trial for cancer

CDC estimates that antibiotic-resistant infections affect at least two million people in the United States each year and drive $35 billion in healthcare system costs annually.

As COO Mr. Papandrea will lead operations including billing, patient support, sales and device production.